News

The Indianapolis-based drugmaker sees orforglipron as a potential global breakthrough treatment for weight loss and other ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
It brings Lilly's total investment in Raheen to $2 billion, doubling the investment the company announced in March 2023.
May 8, 2025 – Today, TIME reveals the second annual TIME100 Health list recognizing the 100 most influential individuals in health.
Eli Lilly and Company (NYSE ... Lilly just does not guide aggressively. David Ricks is very conservative. The stock tends to go down more than six, seven, it tends to go down eight, nine, and ...
Eli Lilly CEO David Ricks signaled he was not interested in such a race and instead is focusing on near-term wins with next-generation GLP-1s and the highly anticipated orforglipron, an obesity ...
But Eli Lilly CEO David Ricks waved off the deal Thursday, telling Yahoo Finance in an interview that the company is focused more on upcoming obesity drugs in its pipeline and sees exclusive deals ...
Eli Lilly is getting closer to bringing a weight loss pill to market, but CEO David Ricks notes certain factors need to be considered to prevent prices from ballooning. The Trump administration ...
David Ricks is the CEO of Eli Lilly, the most valuable drugmaker in the world by market capitalization. Lilly is on the path to become the first trillion-dollar pharma company, fueled by the ...
However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every ...
David Ricks thinks Trump's tariffs will eventually target drugmakers. The results could be harmful to them in more ways than one. Despite this issue, Eli Lilly remains a top stock to buy.
However, some major executives in the sector are not optimistic, including Eli Lilly's (NYSE: LLY) CEO, David Ricks. Let's see what he had to say about the potential impact of tariffs, and what ...